Literature DB >> 6303270

Exercise therapies in peripheral neuropathies.

G J Herbison, M M Jaweed, J F Ditunno.   

Abstract

The treatment of peripheral neuropathies should be aimed at maintaining the range of motion of the joints, re-educating the patient in skilled activities and optimizing the recovery of strength. Many techniques have been described to substitute for, to strengthen and to improve the function of residual innervated muscle; however, not all of these techniques are of unquestioned value. Specifically, electrical stimulation does not appear to enhance reinnervation of totally denervated muscle. Similarly, overstretching weakened muscle may impair the use of paretic muscle. Because overwork may damage partially denervated muscle, brief isometric or isotonic contractions may be more beneficial for increasing strength than a program of habitual exhausting activities.

Entities:  

Mesh:

Year:  1983        PMID: 6303270

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Effect of treadmill exercise on serotonin immunoreactivity in medullary raphe nuclei and spinal cord following sciatic nerve transection in rats.

Authors:  Arthiese Korb; Leandro Viçosa Bonetti; Sandro Antunes da Silva; Simone Marcuzzo; Jocemar Ilha; Mariane Bertagnolli; Wania Aparecida Partata; Maria Cristina Faccioni-Heuser
Journal:  Neurochem Res       Date:  2009-09-23       Impact factor: 3.996

2.  Motor neurone disease: towards better care.

Authors:  B Pentland; K Burford; J D Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

3.  Influence of Exercise on Patients with Guillain-Barré Syndrome: A Systematic Review.

Authors:  Nicholas Simatos Arsenault; Pierre-Olivier Vincent; Bai He Shen Yu; Robin Bastien; Aaron Sweeney
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

4.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.